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1  | C A SE PRESENTATION
A 67-year-old man with a diagnosis of bipolar disorder (BD) Type I 
since he was 35 years old, was admitted to our Memory Clinic in 2016 
because, throughout the last year, his wife had noticed the onset of 
attentional deficits and a significant worsening of motor slowness. 
The patient is married and a father of two, he has worked as a naval 
carpenter and he was retired at the time of the first admission at our 
clinic. He has never smoked nor drunk alcohol. No family history for 
psychiatric or neurodegenerative disease was reported. The patient 
has been monitored by the local psychiatric services throughout his 
life and the psychiatric reports describe his periods of mania, lasting 
for 2-3 years, with the presence of: dangerous driving, sleep disor-
der during which the patient carried out domestic activities in the 
night, expansive behaviour towards women, periods of excessive 
prodigality for hobbies and holidays. These hypo-maniac periods 
were characterized by an increase of energy, impulsiveness and risky 
behaviour. His condition included periods of remission and periods 
of hypomania with extremely depressed mood during which made 
it hard for him to go to work. Long-acting injectable antipsychot-
ics (Haloperidol) were initially dispensed by the psychiatric service. 
Subsequently, about 25 years ago, the patient was started on lithium, 
which was partially affective to control behavioural symptoms that 
remained stable in frequency for at least further 20 years. About ten 
years ago the patient was started with olanzapine. In the last four 
years, while the psychiatric complaints decreased in severity, the pa-
tient has started to develop motor slowness.
Four years ago the patient was visited by the local neurology 
department for signs of bradykinesia, the neurological examination 
performed in 2014 showed signs of akinetic-rigid parkinsonism that 
were believed secondary to the treatment with lithium 300 mg twice 
daily and olanzapine 5 mg. The patient was well-functioning and in a 
condition of good psychopathological balance.
In 2016, the patient was admitted to our Memory Clinic. 
Neurological examination at first admission showed severe parkinson-
ism with moderate-to-severe limb rigidity, marked impairment of finger 
and toe tapping with predominance on the right side. Axial symptoms 
were also present and included reduced postural reflexes, marked neck 
rigidity and limitation of vertical eye pursuit. Dystonia or phantom limb 
phenomenon was absent. Therapy at admission was: Carbolithium 
300 mg 2/daily; Lorazepam 2.5 mg/daily and Olanzapine 5 mg/daily. 
Serum lithium was always within therapeutic range.
Treatment with levodopa was started, up to 800 mg/daily. The 
subsequent evaluations showed the stability of cognition but the 
worsening of motor symptoms. Throughout the last two years, pos-
tural instability worsened with frequent backwards falls and the 
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
202  |     CLINICAL CURIOSITY
vertical smooth limitation of eye movements turned into vertical 
gaze palsy. The cognitive status remained stable, with prominent 
executive dysfunctions. Also, the patient did not develop language 
or severe behavioural deficit during the observational period. The 
patient suddenly died at home from cardiac arrest in January 2019.
The patient's neuropsychological profile was characterized by 
mild impairment of attention and phonemic fluency with normal 
semantic fluency and memory functioning. The executive functions 
were severely affected. Neuropsychiatric examination revealed the 
presence of mild depression and apathy but no psychotic symptom, 
hallucination or disinhibition.
Magnetic resonance imaging revealed an asymmetric cortical 
atrophy with severe involvement of the left frontal and temporal 
regions (left insula, left lateral temporal region, left frontal lobe, es-
pecially on the dorsolateral prefrontal cortex), a moderate atrophy 
in the right frontal regions and in the mesial bilateral frontal regions. 
Also, an area of focal atrophy can be appreciated in the right poste-
rior medial region of the parietal lobe (Figure 1A-H).
Metabolic evaluation with 18-FDG-PET evidenced a diffused 
decrease in cortical metabolism, prominent on the left side. Areas 
of cortical hypometabolism include the frontal dorsolateral, parietal 
and left temporal lobe in toto (Figure 1I-L).
On the DatSCAN evaluation, we observed moderate and asym-
metric reduction of dopamine uptake (Figure 1M).
Progranulin plasma levels were found to be within the normal 
range, thus, no further GRN sequencing was carried out; no expan-
sion of C9ORF72 hexanucleotide repeats was detected.
2  | DISCUSSION
We reported the case of a patient with history of BD who developed 
a progressive supranuclear palsy-parkinsonism (PSP-P) like disease 
Key message
Following a long-standing history of bipolar disorder (BD), 
a patient presented with parkinsonism. Left frontotem-
poral atrophy at magnetic resonance imaging and hypo-
metabolism at positron emission tomography with tracer 
18-fluorine fluorodeoxyglucose were detected. Diagnostic 
criteria for Frontotemporal Dementia, progressive supra-
nuclear palsy-parkinsonism, idiopathic Parkinson's disease 
or drug-induced Parkinson were doubtful. We suggest that 
it was a case of atypical parkinsonism due to frontal degen-
eration, after a long-standing history of BD.
F I G U R E  1   T1 weighted magnetic resonance imaging in axial, coronal and sagittal slices. Moderate-to-severe atrophy can be observed 
in the left lateral temporal regions (B-F), the left insula (F), the left frontal lobe (C-E), especially on the dorsolateral prefrontal cortex (E). 
Also, a moderate atrophy is present in the mesial bilateral frontal regions on the right (C-E). Additionally, an area on focal atrophy can 
be appreciated in the right posterior medial region of the parietal lobe (D). The midbrain is mildly atrophic (H). The positron emission 
tomography with tracer 18-fluorine fluorodeoxyglucose (18-FDG-PET) evidences a diffused hypometabolism in the left frontal dorsolateral 
area, in the left parietal region and in the left temporal lobe in toto (I-L). The SPECT evaluation shows a decrease in the concentration of 
I-ioflupane (I-FP-CIT) in both the caudate-putaminal structures, to a greater extent in the left putamen (M) [Colour figure can be viewed at 
wileyonlinelibrary.com]
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associated with severe brain degeneration, particularly affecting the 
left frontotemporal lobes (Figure 1A-H).
The “neuroprogression” of BD has been conceptualized as the 
progression of neurophysiological and morphostructural alterations 
in BD patients. However, illness trajectories are largely variable and 
scarcely predictable. Moreover, no clear neuropathological marker 
can be ascribable to BD.1 In a recent study, the longitudinal trajec-
tories of frontotemporal dementia (FTD) and psychiatric disorders 
with behavioural symptoms were examined and the results provide 
strong evidence of a faster worsening of the symptoms in FTD, with 
a stable profile in psychiatric conditions. This may provide grounds 
to assume that our patient's clinical trajectory is due to a frontal lobe 
neurodegeneration, rather than the evolution of a purely psychiatric 
condition.2 Another recent study, describing the syndromic overlap 
between frontotemporal lobar degeneration and several psychiatric 
disorders, reported a similar case. Particularly, a patient diagnosed 
with BD type I at the age of 33, was eventually diagnosed with sus-
pected FTD at the age of 68, presenting with frontal and temporal 
bilateral atrophy and hypometabolism.3
The singular clinical trajectory of the case and the imaging find-
ings rise the question whether the diagnosis of PSP-P is a reliable 
conclusion or may rather be classified within the spectrum of differ-
ent neurodegenerative disorders such as frontotemporal dementia 
(FTD with parkinsonism) or corticobasal degeneration (ie PSP-CBS). 
Furthermore, the moderate nigrostriatal denervation detected at 
the DatSCAN could point towards a clinical classification of a PSP-
mimic rather than a pure PSP.
Cases of BD evolving into FTD have been reported.4 However, 
clinical diagnostic markers for FTD, particularly the behavioural vari-
ant (bv-FTD), include early clinical and behavioural symptoms that 
were lacking at onset and have been absent throughout his illness. 
Additionally, the genetic analysis was negative for mutation of GRN 
and C9ORF72, which have been associated with BD-FTD phenotypes.3
Although the current criteria for PSP also include forms of PSP 
with corticobasal phenotype (PSP-CBS), classical cortical signs of 
CBS were lacking in our patient.
Lithium and neuroleptics drug-induced parkinsonism has been 
described, but not cases of atypical parkinsonism. Additionally, oc-
ular gaze palsy due to lithium presents with horizontal gaze palsy 
associated with downbeat nystagmus, instead of vertical gaze palsy.
The width of PSP spectrum is now well-recognized from the clin-
ical and neuroradiological perspective. Furthermore, new genetic 
mutations in PSP mimics and atypical phenotypes are increasingly 
acknowledged.5
The clinical phenotype expressed by our patient does not 
allow a reliable diagnosis of PSP or idiopathic PD, therefore, here 
we propose this case as atypical parkinsonism due to a frontotem-
poral lobar degeneration developing after a long history of BD.
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